1. Richard DeSchutter

    0 Comments Leave a Comment

    1-1 of 1
    1. Mentioned In 1 Articles

    2. Sermonix Pharmaceuticals Adds Three New Members to Its Board of Directors

      Sermonix Pharmaceuticals Adds Three New Members to Its Board of Directors
      COLUMBUS, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical company focused on the development and commercialization of female-specific oncology products, today announced the addition of Richard U. DeSchutter, Michael A. Friedman, M.D., and Stephen Rubino, Ph.D., to its board of directors...
      Read Full Article
    3. 1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content